Nomic

Nomic, headquartered in Montreal with labs and offices in Boston, is a bioengineering company focused on making the human proteome as accessible as the human genome. Originally known as nplex biosciences, Nomic has developed the nELISA platform, a next-generation nanotechnology-based ELISA system, to advance high-throughput protein profiling. The company secured $17 million in Series A funding in 2021 to support the development and commercialization of its proteomic platform. Nomic collaborates with pharmaceutical companies like GlaxoSmithKline and aims to revolutionize proteomics accessibility.

Recent Posts by Nomic

1-7 of 7